Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2687-2690

  Chen, Jung T A ^a   Ho, William L ^a   Cheng, Ya Wen ^b   Lee, Huei ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

NSCLC; p53 mutation; Sputum smears

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; EARLY DIAGNOSIS; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM ANALYSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; GENES, P53; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RNA; SPUTUM;

EID: 0033860898     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Department of Health, The Executive Yuan, Republic of China: General health statistics, in: Health and Vital Statistics, Republic of China, Taipei, Taiwan, ROC, 1996, pp. 88-111.
2. Parker S, Tong T and Bolden S: Cancer statistics, CA Cancer J Clin 47: 5-27, 1997.
3. Statistics and Information Department: Vital Statistics 1990 Japan, Vol. 1. Tokyo, Japan, Ministry of Health and Welfare, 1997, pp. 96-97.
4. Berrino F, Sant M and Verdecchia A: Survival of Cancer Patients in Europe. The EUROCARE Study. Lyon, France, IARC Scientific Publications No. 132, 1995.
5. Skarin A: Respiratory tract and head and neck cancer, (Rubenstein E, Federman D, eds), Scientific American Medicine. New York, Scientific American, 1995, pp. 1-35.
6. Salgia R and Skarin A: Molecular abnormalities in lung cancer. J Clin Oncol 16: 1207-1217, 1998.
7. Hussain SP and Harris CC: Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 58: 4023-4037, 1998.
8. Greenblatt M, Bennett W and Hollstein M: Mutations in p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
9. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH: Specific loss of apoptotic in a human tumor but not cell-cycle arrest function in a human tumor derived p53 mutation. EMBO J 15: 827-838, 1996.
10. Gerwin BJ, Spillare E and Forrester K: Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transformation factor beta 1. Proc Natl Acad Sci USA 89: 2759-2763, 1992.
11. Dittmer D, Pati S and Zambetti G: Gain of function mutations in p53. Nat Genet 4: 42-46, 1993.
12. Sidransky D and Hollstein M: Clinical implications of the p53 gene. Annu Rev Med 47: 285-301, 1996.
13. Mitsudomi T, Lam S and Shirakusa T: Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer. Chest 104: 362-365, 1993.
14. Lee J, Yoon A and Kalapurakal S: Expression of p53 oncoprotein in non-small-cell lung cancer: A favorable prognostic factor. J Clin Oncol 13: 1893-1903, 1995.
15. Mao L, Hruban RH, Boyle JO, Tockman M and Sidransky D: Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54: 1634-1637, 1994.
16. Jacobson DR, Fishman CL and Mills NE: Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer. Ann Oncol 6: S3-8, 1995.